From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Advanced Oncotherapy – Scraping The Barrel - what is Crispin Odey doing with his client's cash?: SELL

By Nigel Somerville, the Deputy Sheriff of AIM | Monday 12 December 2022


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


AIM-listed Advanced Oncotherapy (AVO) has announced that it has raised another £1.5 million from an existing institutional investor at 25p per share, the par price below which the law prevents the issue of confetti. With the stock having closed last week at just 16.75p, this is surely pure madness on the part of that institutional investor – who we are reliably told is none other than Crispin Odey. How his compliance officer is allowing this, heaven only knows.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

GEX

Georgina Energy: Lyin’ Yet again

Wednesday »

Bearcast

Tom Winnifrith Bearcast: Bracing myself

Time left: 21:35:23